Treatment shows promise in breast, lung, other cancers. FMTNews AstraZeneca
LONDON: AstraZeneca could pay up to US$6 billion to Japan’s Daiichi Sankyo to develop and market a type of targeted cancer treatment in the second multi-billion dollar cancer drug collaboration between the two companies.
The drugmakers signed a near US$7 billion deal last year for a breast cancer treatment, now called Enhertu, which is being tested in other tumour types too.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
India’s Ambani now the world’s fifth richest personWith a US$77 bil fortune, he is the only Asian in the top 5. FMTNews WorldRichest Billionaires Ambani
Read more »
US doubles investment on potential Covid-19 vaccine to nearly US$1 bilUS biotech firm Moderna expects to produce 500 million doses a year starting in 2021. FMTNews Vaccine Covid19 US
Read more »
Royal Selangor's iconic comic book covers series takes flight with SupermanRoyal Selangor pays homage to iconic superhero comic book covers with new sculpture series.
Read more »
Why settle for only US$3.9 bil from Goldman Sachs, asks Guan EngThe former finance minister says the PH-led government had claimed US$7.5 billion from the investment bank. FMTNews GoldmanSachs LGE
Read more »
YOURSAY | If no money is missing, why must Goldman Sachs pay us billions?'Former AG Apandi believed nothing was lost, no money was stolen…'
Read more »
US doubles spending on potential Covid-19 vaccine to nearly US$1 billion | New Straits TimesWASHINGTON: The United States has doubled its investment – to nearly US$1 billion – to expedite development of a potential COVID-19 vaccine by American firm Moderna, which on Monday begins the decisive final phase of clinical trials.
Read more »